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Risk factor profile of 
coronary artery disease in 
black South Africans
Very little is, however, known regarding the cause, risk factor pro-
file and clinical presentations of CAD in the black South African 
population. Steyn et al.(8) determined in the INTERTHEART study 
that 89.2% of the risk for an initial myocardial infarct in Africans can 
be accounted for by five risk factors namely: current/former to-
bacco smoking, self-reported hypertension and diabetes, abdomi-
nal obesity measured as waist to hip ratio and lipoprotein ApoB/
ApoA-1 ratio. Contrasting gradients were however, found in 
socioeconomic class, risk factor patterns and myocardial infarction 
risk between different ethnic groups.
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IntroductIon                                                               
While age-adjusted cardiovascular disease (CVD) death rates have 
declined in several developed countries, rates of CVD have 
increased disconcertingly in low- and middle-income countries.(1,2) 
Coronary artery disease (CAD) specifically, has historically been 
remarkably rare in black South Africans, but studies are now 
showing an increase in prevalence especially in urban areas as a 
result of urbanisation.(3-5) 
Recognised risk factors that have been shown to be affected by 
urbanisation in the Transition and Health during Urbanisation in 
South Africans (THUSA) study include increases in hypertension, 
obesity, smoking habit and hyperfibrinogenaemia.(6) Changes in 
dietary intakes during urbanisation are considered to play a 
prominent role in the observed increase in risk factors.(7) With 
urbanisation, there is also an increase in socio-economic status, 
which is usually accompanied by an increase in other risk factors 
such as obesity and physical inactivity.(8)
objectives: the aim of this study was to investigate the risk 
factor profile of coronary artery disease (cAd) in black 
south Africans. the study was motivated by the increased 
prevalence of cAd in south Africa, probably as a result of 
urbanisation. despite this increase, however, very little is 
known regarding the cause, risk factor profile and clinical 
presentations of cAd in the black south African population. 
design: A case control study was performed investiga- 
ting 40 (33 men, 7 women) angiographically defined cAd 
patients and 20 (13 men and 7 women) age and body 
composition matched controls. 
results: there was no difference in physical activity, socio-
demographic factors or dietary intakes between the cAd 
and control group, except for the cAd patients consuming 
less vit c (40.9 vs 61.3 mg). the cAd group had signifi- 
cantly higher LdL-c, fasting glucose and crP. there was 
also a significantly higher prevalence of smokers (35 vs 10%), 
hypertension (95 vs 75%) small dense LdL (73 vs 15%) and 
insulin resistance (M-value of 4.15 vs 12.5 mg/kg/min) in the 
cAd compared to the control group. In a logistic regression 
model, small dense LdL and insulin resistance were the 
main predictors of cAd.
conclusions: black south African cAd patients had in-
creased levels of the same risk factors that are typically seen 
in caucasians with insulin resistance and small dense LdL 
being particularly significant in their contribution.
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It is not yet known what the individual contribution of each of 
the known risk factors for CAD development in black Africans is. 
Differences for instance occur in the prevalence of individual risk 
factors in black Africans compared to Caucasians such as hyper-
tension and the lipid profile. The African population is known to 
be especially vulnerable to hypertension.(9) Kearney et al.(10) pre-
dicted that by 2025, 73.6 million men and 77.1 million women in 
sub-Saharan Africa will be hypertensive with urbanisation signi-
ficantly contributing to this increased prevalence.(7) Black South 
Africans in general, on the other hand seem to have a favourable 
lipid profile with lower total cholesterol (TC) and higher high 
density lipoprotein cholesterol (HDL-C) levels than other ethnic 
groups in South Africa.(6) Black Africans with heart disease in the 
Heart of Soweto study also had lower cholesterol levels than 
other ethnicities.(5) Nethononda et al.(11) furthermore demonstra-
ted that black South African CAD patients in their study, had 
cholesterol levels within the target range recommended by the 
adult treatment panel III (ATPIII) guidelines of the National 
Cholesterol Education Programme (NCEP).
Therefore, due to the increase in prevalence of CAD and to better 
understand the risk factor profile and pathophysiology thereof in 
black South Africans, we undertook a study to compare dietary 
intakes, physical activity level, socio-demographic background and 
biochemistry of angiographically defined black South African CAD 
patients with a control group from a similar socio-demographic 
background. We excluded the complex and confounding effects 
of diabetes and obesity by excluding diabetic patients and by 
matching CAD cases and controls for not only body mass index 
(BMI) but also for waist circumference and waist-hip ratio. 
Methods                                                                                             
Study population
Forty black patients (33 males, 7 females) with documented CAD 
who attended the Chris Hani Baragwanath hospital in Soweto 
were included after signing informed consent. Ethical approval was 
obtained from the Wits Health Consortium (No: 010102). 
Coronary artery disease was defined as more than 50% lesions in 
one or more major coronary arteries, seen with a diagnostic 
coronary angiogram in the previous 24 months. Subjects with 
previous myocardial infarction (MI) had to be at least three 
months post-MI before the study. Patients with severe hyper-
cholesterolemia (untreated TC of >7.5mmol/L or familial hyper-
cholesterolaemia), previously diagnosed diabetes mellitus or 
who were HIV-infected were excluded. Other exclusion criteria 
included any overt liver, renal or thyroid disease and smoking in 
excess of 20 cigarettes per day. Four weeks before the study 
started, lipid-lowering medications such as statins and fibrates 
were discontinued. Any other drugs that might alter lipid levels 
and/or insulin resistance such as thiazide diuretics, beta-blockers 
or steroids were stopped three days before sample collection. 
Patients and controls were also asked to refrain from smoking for 
12 hours prior to sample collection.
Twenty black healthy volunteers (13 men and 7 women) from a 
similar socio-demographic background and who visited the cardiac 
clinic of the same hospital, matched for age, BMI, waist circum-
ference and waist-hip ratio were included as a control group. This 
was done in order to exclude the confounding effects of age and 
weight differences. The control group had no evidence of coronary 
atherosclerosis on coronary angiography. The same exclusion cri-
teria, as for the CAD patients, applied for the control group.
MAterIALs And Methods                                          
Demographic information, medical history, medication use and 
smoking status were obtained using questionnaires. A standardised 
and validated quantitative food frequency questionnaire, developed 
for the African population, together with a food portion photo 
book were used to determine dietary intakes.(12,13) The nutrient 
intakes were analysed using the Medical Research Council’s 
FoodFinder3 programme, which is based on the South African 
Food composition tables.(14) A standardised Physical Activity 
questionnaire(15) was used to calculate the Physical Activity Index. 
Anthropometrical measurements consisted of height, weight and 
waist and hip circumference. Height and weight were used to 
calculate BMI. 
Fasting blood samples were collected by a qualified nursing sister. 
Serum was prepared for C-Reactive protein (hs-CRP), TC, HDL-C, 
triglycerides (TG), Apo A1, Apo B, Lp(a), pro-insulin, insulin, 
C-peptide, adiponectin, leptin, free fatty acids (FFA), and uric acid 
while plasma for glucose determination was collected in fluoride 
tubes. Urine was collected for measurement of urinary albumin. 
Blood samples were centrifuged at 1 500g, for 20 minutes within 
1 hour of collection and then stored at -70°C until analysis. 
6Glucose, TG, TC, HDL-C, hs-CRP, uric acid and urinary albumin 
were determined by enzymatic colorimetric methods using a 
Hitachi automated clinical analyser and reagents (Roche Diagnos-
tics GmbH, Mannheim, Germany) in a routine laboratory. Low 
density lipoprotein cholesterol (LDL-C) concentrations were 
calculated using the Friedewald equation.(16) LDL subfractions were 
measured in serum by linear, polyacrylamide gel electrophoresis 
using a Quantimetrix Lipoprint System LDL Subfractions kit 
(Quantimetrix, CA, USA). Apo A1, Apo B and Lp(a) were analysed 
using immunoturbidimetric assays (Tina-quant, Roche Diagnostics 
GmbH, Mannheim, Germany). Insulin and c-peptide were ana- 
lysed using chemiluminescent immunometric assays (IMMULITE, 
Siemens Medical Solutions Diagnostics Ltd, Gwynedd, UK). 
Proinsulin was analysed using an enzyme linked immunosorbend 
assay (ELISA) (Dako-Cytomation Ltd, Cambridgeshire, UK). Leptin 
and adiponectin were analysed with sandwich ELISA’s (Quantikine 
Immunoassays, R & D Systems, Minneapolis, USA). Free fatty acids 
were determined with an enzymatic colorimetric assay (NEFA, 
Roche Diagnostics GmbH, Mannheim, Germany). Insulin-mediated 
glucose disposal (M-value) was determined using the hyper-
insulinaemic euglycaemic clamp technique and expressed as mg/kg/
min with a normal value being >5.0mg/kg/min and a value below 
this indicating insulin resistance.(17) Intima media thickness (IMT) was 
measured using B-mode ultrasound at the optimum angle of 
interrogation at the flow tip divider, the common carotid artery, 
external carotid artery and internal carotid artery at the bifurca- 
tion as described in detail by Holland et al.(18) 
stAtIstIcAL AnALysIs                                                     
Statistical analysis of data was done using the computer software 
package Statistica® version 8. Data is reported as median (25 – 75 
percentile) for non-parametric data or as mean (standard devia-
tion) for parametric data. A p-value ≤0.05 was regarded as sta-
tistically significant. Independent T-tests were done on parametric 
data and for non-parametric data, the Mann Whitney U test was 
used when comparing the CAD patients to the control group. 
Analysis of Co-Variance (ANCOVA) was used to determine 
differences between the CAD and control group after adjusting 
for possible confounding effects of age. Only variables that were 
found to be affected by age were adjusted for age. For the 
categorical variables, the Chi-square test was used. Spearman Rank 
order correlations were done to determine associations between 
risk factors and diet, physical activity and socio-demographic 
variables. Logistic regression was used to determine predictors for 
categorical variables such as LDL size and CAD.
resuLts                                                                             
The clinical and biochemical characteristics of the study population 
are shown in Table 1. The CAD patients had significantly higher 
median LDL-C, fasting glucose, CRP and significantly lower TG and 
M-values than the control group. The median M-value of the 
CAD group was 4.15mg/kg/min, indicating the presence of insulin 
resistance.(17) Although not significantly so, TC was higher in the 
CAD than in the control group (5.42 vs 4.63mmol/L). The TC 
level of the CAD group was furthermore higher than the target 
range (<5.2mmol/L) recommended by the ATP III criteria of 
NCEP.(19) LDL-C was higher than the ATP III target range in both 
groups (<2.59mmol/L). The CAD group had non-significantly 
higher IMT than the control group (1.1 vs 0.93mm). Forty five 
percent of the control subjects and 70% of the CAD patients had 
increased IMT, using 0.8mm as cut-off.(20) IMT correlated signifi-
cantly with age (r=0.47; p=0.0005), CRP (r=0.45; p=0.002) and 
fasting plasma glucose (r=0.29; p=0.46). Adjusting for age affected 
only CRP, leptin and IMT. After adjustment for age, CRP was no 
longer significantly different between the CAD and control group 
(p=0.2), while leptin levels were now significantly lower in the 
CAD than the control group (p=0.023), the difference in IMT 
remained non-significant (p=0.97).
There was a significantly higher prevalence of smokers (35 vs 
10%), hypertension (95 vs 75%) and small dense LDL (73 vs 15%) 
in the CAD compared to the control group. When subdividing 
the population based on LDL-size, 90% of the subjects with small 
dense LDL were in the CAD group. The subjects who did not 
smoke had a similar distribution of small dense and large buoyant 
LDL (46 vs 54%) while in the smokers, 87% of subjects had small 
dense LDL. A similar trend can be seen for metabolic syndrome. 
Patients without the metabolic syndrome had a similar distribution 
of small dense and large LDL (48 vs 52%) while 66% of those with 
the metabolic syndrome had small dense LDL, compared to 33% 
who had large buoyant LDL. Using logistic regression, age and 
M-value were the only predictors of LDL-size and the subjects with 
large buoyant LDL had a significantly higher M-value than the 
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subjects with small dense LDL (8 vs 3.8 mg/kg/min) who, based on 
the M-value were considered to be insulin resistant.
The metabolic syndrome as classified by the International Dia- 
betes Federation(21) was present in 24 (60%) of the CAD patients 
compared to 8 (40%) of the controls. Although this is a marked 
difference, it was not found to be statistically different. Details 
pertaining to this high prevalence of metabolic syndrome in the 
CAD cases have been published elsewhere.(22) 
Using a logistic regression model that included the risk markers 
that differed between the CAD and control group, M-value, CRP 
and LDL size were the main predictors of CAD. 
The dietary intake, physical activity and socio-demographic infor-
mation of the CAD patients and control group are reported in 
Table 2 and compared to the dietary guidelines for the prevention 
of CAD. The only nutrient that was found to be significantly 
tAbLe 1: clinical and biochemical characteristics of study population
Data expressed as median [25 – 75 percentile].  CAD: coronary artery disease, BMI: body mass index, HDL: high-density lipoprotein, LDL: low density lipoprotein, CRP: c-reactive protein levels. 
*p value in brackets after adjustment for age
 cAd patients n = 40 control n = 20 P value
Gender (males/females) 33/7 13/7 
Age (years) 55 [51 – 61] 49.5 [44.5 – 57.5] 0.07
BMI (kg/m2) 28 [24.5 – 31] 27.5 [24.5 – 33.5] 0.73
Waist circumference (cm) 98 [88.5 – 106] 94 [83 – 100.5] 0.23
Smoking (n) 14 (35%) 2 (10%) 0.02
Hypertension (n) 38 (95%) 15 (75%) 0.02
Total cholesterol (mmol/L) 5.42 [4.63 – 6.1] 4.63 [3.88 – 5.38] 0.09
HDL cholesterol (mmol/L) 1.14 [0.98 – 1.39] 1.15 [0.95 – 1.41] 0.34
LDL cholesterol (mmol/L) 3.31 [2.64 – 4.07] 2.85 [2.2 – 3.5] 0.041
Triglycerides (mmol/L) 1.38 [1.03 - 2.23] 1.44 [1.02 – 1.64] 0.05
LDL size (n with small LDL) 29 (73%) 3 (15%) <0.0001
Apo A1 (mg/dL) 133.1 [104.8 – 148.3] 130 [106.2 – 141.5] 0.30
Apo B (mg/dL) 101.3 [76.5 – 115.1] 83.9 [72.7 – 99.7] 0.11
Apo B / Apo A1 0.82 [0.58 – 0.91] 0.66 [0.57 – 0.82] 0.18
Lp(a) (mg/dL) 51.45 [39.6 – 76.7] 56.1 [24.4 – 71.1] 0.48
Metabolic Syndrome (n) 24 (60%) 8 (40%) 0.14
Fasting glucose (mmol/L) 5.11 [4.7 – 5.4] 4.6 [3.9 – 5.1] 0.009
Insulin (mIU/L) 5.29 [3.29 – 12.2] 3.93 [2 – 6.32] 0.10
M-value (mg/kg/min) 4.15 [3 – 5.15] 12.5 [5.75 – 14.15] <0.0001
Proinsulin (pmol/L) 1.31 [0.76 – 2.86] 1.73 [0.75 – 2.58] 0.72
C-peptide (μg/L) 1.1 [0.69 – 1.51] 0.62 [0.4 – 1.41] 0.22
Hs-CRP (mg/L) a 4.72 [2.48 – 8.00] 2.32 [0.91 – 4.46] 0.026 (0.2)
Adiponectin (mg/mL) 11.32 [5.91 – 30.45] 12.38 [7.85 – 18.53] 0.88
Leptin (ng/mL)* 7.71 [4.25 – 13.33] 12.9 [3.82 – 19.78] 0.35 (0.023)
Free fatty acids (mmol/L) 0.84 [0.63 – 1.04] 0.85 [0.76 – 1.06] 0.76
Uric acid (mmol/L) 0.39 [0.35 – 0.45] 0.43 [0.34 – 0.48] 0.42
Urinary albumin (mg/L) 6 [2.9 – 20.4] 4 [0.4 – 16] 0.458
Intima media thickness (mm)* 1.1 [0.82 – 1.32] 0.93 [0.6 – 1.43] 0.16 (0.97)
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tAbLe 2: comparison of dietary intake between cAd patients, controls and dietary recommendations for prevention of cAd
Data expressed as median [25 – 75 percentile] or mean±standard deviation;  *Equivalent to less than 1 unit of alcohol per day,  †P = 0.049,  % of TE: percentage of total energy
‡Physical activity index: 1- 3.33: inactive; 3.34 – 6.67: moderately active; >6.67 most active. §Income categories: 2:R101-500; 3:R501-1000; 4:R1000-2000; 5:R2000-R3000; 6:>R3000.
#Education categories: 2:< std 6; 3: Std 6-8; 4: Std 6-8 plus trade; 5: Std 9-10.
nutrient Recommendations cAd patients controls
Energy (kJ) Balance calorie intake and physical a 10566 [9156 – 13299] 9630 [7725 – 12716]
 ctivity to achieve or maintain a healthy 
 body weight(42)
Protein % of TE ≈ 15 % of TE(42) 12.98  [12.04 – 15.7] 13.46 [12.49 – 15.09]
Carbohydrate % of TE 50 - 60% of TE(19) 53.52±5.93 53.08±4.89
Total fat % of TE 25-35% of TE(43)  27.75±5.99 29.29±4.91
Saturated fatty acids % of TE <7% of TE(19;42;43) 8.34±2.05 9.05±2.42
Trans fatty acids % of TE < 1%(19;42;43) 0.24 [0.14 – 1.58] 0.47 [0.27 – 0.83]
Cholesterol (mg) < 300mg(42) 315.7 [267.4 – 420.7] 289.7 [187.4 – 523.1]
Polyunsaturated fatty acids  % of TE up to 10 % of TE(19) 6.96±2.17 7.84±2.37
Monounsaturated fatty acids  % of TE Up to 20 % of TE(19) 9.85±2.70 9.38±1.79
Fibre (g) > 25g per day(19;43) 21.73 [17.06 – 30.6] 17.31 [14.43-26.23]
Added sugar (g) Minimise intake of foods and  66.13[49.04 – 97.41] 63.77 [33.57 – 86.83]
 beverages with added sugars(42) 
Sodium (g) Choose and prepare food with little 1.81±0.62 2.04 ± 0.58 
 or no salt 
 2.3g/day – sodium(42) 
Alcohol (g) If you do – in moderation 0 [0 – 10.49] 0 [0 – 2.63]
 2 drinks per day – men Men: 2.5 [0.00 – 10.49]* Men: 1.21 [0.00 – 4.66]*
 1 drink per day – woman(42,43) Female: 0 [0.00 – 0.00] Female: 0 [0.00 – 0.00]
Selenium (mg) 55 mg(19) 40.21 [31.43 – 60.3] 45.57 [29.4 – 59.31]
Vitamin C (mg) Male: 90mg 40.9 [30.3 – 66.9]† 61.3 [50.4 – 125]†
 Female: 75mg(44) Men: 41 [29.9 – 66.9] Men: 64.4 [54.9 – 143]
  Female: 39 [34.7 – 183] Female: 61.3 [41.4 – 97]
Folate (μg) 400μg(44) 272.4±105.42 244±69.44
Vitamin E (mg) 15mg(44) 10.68 [8.07 – 15.93] 12.71 [7.92 – 15.6]
Vitamin B6 (mg) Male: 1.7mg 1.38 [1.12 – 1.78] 1.55 [1.17 - 1.88]
 Female: 1.5mg(44) Men: 1.4 [1.12 – 1.78] Men: 1.52 [1.29 – 1.68]
  Female: 1.34 [1.06 – 1.87] Female: 1.57 [1.08 – 1.88]
B-Carotene (mg) 3 – 6mg(44) 3.09 [1.79 – 4.39] 2.55 [1.42 – 4.28]
Physical activity index‡ >30 min exercise most days of  5.19 [4.21 – 6.29] 4.25 [3.36 – 5.29]
 the week(42) 
Income§  3 [3 – 6] 3 [1 – 5.5]
Education#  3 [2 – 5] 3.65 [2 – 5]
Housing (brick/informal)  37/3 19/1
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different was the vitamin C intake (p=0.049) with CAD patients 
having a significantly lower intake than the control group. No 
differences were found in physical activity, income, and type of 
housing or education level between the groups. Both the CAD 
patients and the control group had a median Physical Activity 
Index that fell in the moderately active category.
Both the CAD and the control group had a relatively high total 
energy intake (±10 000kJ) in comparison with their physical acti-
vity as can be seen by their increased median BMI (28 and 
27.5kg/m2). In general, the macronutrient distribution was within 
and the micronutrient intakes below the recommended ranges 
for prevention of CAD for both groups. Although total fat intake 
was within recommended ranges, the saturated fatty acid intake 
was above the recommended ranges and cholesterol intake was 
at the upper limit, while the intake of fibre, folate, selenium vitamin 
B6, vitamin C and E were all below the recommended intake, for 
both the CAD patients and the control group. The women in both 
the control and CAD group did not consume any alcohol. 
dIscussIon                                                                     
The purpose of this study was to help determine the risk factor 
profile and clinical presentations of CAD in black South Africans 
by excluding the confounding metabolic derangements that ac-
company the known risk factors, diabetes and obesity. The CAD 
patients had a higher prevalence of smoking, hypertension, small 
dense LDL and metabolic syndrome with specific emphasis on 
insulin resistance as well as increased LDL-C, TC, CRP and fasting 
glucose than the controls. These factors are all documented to be 
involved in atherosclerosis.(23-25) The decreased vitamin C intake 
together with increased smoking may confer additional risk through 
increased oxidative stress.(26) 
The main predictors of the development of CAD in this black 
South African population were small dense LDL and insulin 
resistance. While more CAD patients had metabolic syndrome 
(60%), compared to the control group (40%), it was insulin re-
sistance per se that seemed to be the major distinguishing factor. 
By excluding overt diabetes and matching for body fat distribution, 
it was possible to determine the independent contribution of in-
sulin resistance amongst the many components of the metabolic 
syndrome. Insulin resistance, as well as the resultant hypergly-
caemia, contribute to atherosclerosis through several mechanisms 
including modification of the lipid metabolism to produce a pro-
atherogenic lipid profile, inflammatory signalling pathways such as 
NF-kB, MAP kinase and protein kinase C, direct effects on the 
vasculature, oxidative/mitochondrial stress and genomic stress.(27,28) 
The lower leptin levels observed in the CAD group may further-
more facilitate the insulin resistance seen in this group. Leptin is 
considered to improve peripheral insulin sensitivity and modulates 
pancreatic ß–cell function.(29,30) 
Small dense LDL confer atherogenic risk through increased trans-
endothelial transport, increased susceptibility to oxidation, reduced 
LDL receptor affinity, increased binding to intimal proteoglycans 
and increased formation of proaggregatory and vasoconstrictor 
mediators.(31-33) Some controversy still exists, however, regarding 
the independent predictive role of small dense LDL in CVD. The 
vast majority of both cross-sectional and prospective epidemiolo-
gical studies have indicated a significant association between small, 
dense LDL and increased coronary heart disease risk. Only some 
studies, however, found it to be an independent predictor once 
adjusting for confounding variables such as increased plasma TG 
and decreased HDL-C levels(34,35) that frequently accompany small, 
dense LDL. The CAD patients in this study did, however, not have 
decreased HDL-C nor increased TG, while 75% had small, dense 
LDL, suggesting that in the black South African population, LDL-size 
may independently confer additional risk.
From the results it seems that insulin resistance and to a lesser 
extent, smoking are strongly related to the presence of small 
dense LDL. Insulin resistance has also in the literature been shown 
to be strongly related to LDL size.(36,37) It is suggested that in 
insulin resistance, non-esterified fatty acids released by adipocytes 
provide more triglycerides for VLDL production as a result of a 
lack of inhibition of hormone-sensitive lipase resulting in the pro- 
duction of small dense LDL.(38) Insulin resistance furthermore 
expedites cholesteryl ester transfer protein-mediate exchange of 
LDL cholesterol ester for VLDL triglycerides. This newly acquired 
LDL triglyceride undergoes lipolysis by hepatic and lipoprotein 
lipase, to form small dense LDL.(38,39) It is therefore possible that 
the high prevalence of small dense LDL present in the CAD patients 
may, at least in part, be caused by the insulin resistance. From the 
results it is also clear that while non-smokers had an equal 
10
distribution of LDL particle size, smokers had a significantly higher 
prevalence of small dense LDL than large buoyant LDL. This 
suggests that smoking may contribute to the development of small 
dense LDL. Very little data is available regarding this in the litera-
ture and well controlled intervention studies are required to 
determine whether smoking can alter LDL size. 
In contrast with the results of Nethononda et al.,(11) the CAD 
patients in this study had both moderately increased TC and LDL-C 
levels. The controls did however also have increased LDL-C. This 
may be the result of the health transition associated with 
urbanisation affecting the previously reported protective lipid 
profile of black South Africans. 
The CAD patients had a significantly lower intake of vitamin C 
than the controls, most probably reflecting a lower intake of fresh 
fruit and vegetables. No other differences were observed in the 
dietary intakes between the CAD patients and controls having 
similar macro- and micronutrient distributions. It is however 
possible that while current diets of the patients and controls did 
not differ significantly, differences in dietary intakes during earlier 
stages of life may have been involved in the early development of 
atherosclerosis. It should also be considered that differences in 
dietary intakes are not only detected by use of nutrient analysis 
but also by use of food consumption patterns. Nutrient analysis 
should therefore be used in conjunction with food consumption 
patterns to determine the contribution of diet to CAD develop-
ment in black Africans. Furthermore there was no difference in 
physical activity (moderately active) nor was there any differences 
in socio-demographic profile as both groups came from the same 
urban environment. One possible contributing factor that was not 
measured in this study may be mental stress.  Differences in coping 
skills, for example, have been shown to increase inflammatory 
responses(40) and affect cardiometabolic risk,(41) despite all parti-
cipants having a similar socio demographic background. It is also 
possible that the use of questionnaires to determine self reported 
dietary intakes and physical activity were not sensitive enough to 
distinguish between subtle differences that may contribute to the 
development of CAD.
In conclusion, black South African CAD patients had increased 
levels of the same risk factors that are typically seen in Caucasians 
with insulin resistance and small dense LDL being particularly 
significant in their contribution. Only modest differences were 
observed between patients and controls for other risk factors. 
Apart from a lower vitamin C intake (possibly an indication of 
lower fruit and vegetable intake), no differences in dietary intakes 
and physical activity were observed between the CAD and control 
groups when matching for body fat, and both groups consumed 
more energy than required for a healthy body weight. It should 
be kept in mind that causality cannot be determined with a case 
control study design, and that generalisation of the study results 
should be done with caution due to the small sample size. Emerging 
data and our increasing understanding of the risk factor profile and 
pathophysiological processes involved in the increasing preva- 
lence of CAD in black South Africans may have significant 
implications for the applicability of current public health dietary 
guidelines for the prevention of CAD in this group. Future research 
should be directed towards determining the cause of the insulin 
resistance and high prevalence of small dense LDL as possible 
strategies for preventing CAD in black South Africans.
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